Peptide vaccine combined adjuvants modulate anti-tumor effects of radiation in glioblastoma mouse model TAT Tran, YH Kim, THO Duong, S Jung, IY Kim, KS Moon, WY Jang, ... Frontiers in Immunology 11, 1165, 2020 | 16 | 2020 |
Feasibility of dendritic cell-based vaccine against glioblastoma by using cytoplasmic transduction peptide (CTP)-fused protein antigens combined with anti-PD1 YH Kim, TAT Tran, THO Duong, S Jung, IY Kim, KS Moon, WY Jang, ... Human Vaccines & Immunotherapeutics 16 (11), 2840-2848, 2020 | 8 | 2020 |
Branched multipeptide immunotherapy for glioblastoma using human leukocyte antigen-A* 0201-restricted cytotoxic T-lymphocyte epitopes from ERBB2, BIRC5 and CD99 YH Kim, HJ Lee, SI Jung, JJ Lee, WY Jang, KS Moon, IY Kim, S Jung, ... Oncotarget 7 (31), 50535, 2016 | 7 | 2016 |
Natural killer cell therapy potentially enhances the antitumor effects of bevacizumab plus irinotecan in a glioblastoma mouse model TAT Tran, YH Kim, THO Duong, JL Thangaraj, TH Chu, S Jung, IY Kim, ... Frontiers in Immunology 13, 1009484, 2023 | 4 | 2023 |
The long multi-epitope peptide vaccine combined with adjuvants improved the therapeutic effects in a glioblastoma mouse model TAT Tran, YH Kim, GE Kim, S Jung, IY Kim, KS Moon, YJ Kim, TK Lee, ... Frontiers in Immunology, 6335, 2022 | 3 | 2022 |
Branched multipeptide-combined adjuvants potentially improve the antitumor effects on glioblastoma YH Kim, S Jung, IY Kim, KS Moon, WY Jang, HJ Lee, JJ Lee, TY Jung Journal of Immunotherapy 44 (4), 151-161, 2021 | 2 | 2021 |